By: Jill Seladi-Schulman
Peter Hansen/Istockphoto Comparing Oral vs. Injectable Semaglutide
Jill Seladi-Schulman is a journalist who writes for Healthline Media, Inc. Her articles cover a wide range of health topics, including cancer, pulmonary hypertension, ALS, kidney failure, Crohn's disease, arthritis, muscular dystrophy, and aplastic anemia. She provides information on symptoms, diagnosis, treatment, and outlook for these conditions, as well as the use of physical therapy in managing certain diseases.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Jill Seladi-Schulman's coverage predominantly focuses on medical conditions, treatment options, and comparisons. Her articles often cite data and delve into industry-specific analysis related to health and healthcare.
For those looking to reach out effectively, it would be beneficial to provide fact-based insights backed by reputable sources or studies when pitching relevant medical conditions, treatment methods, or comparative analyses within the healthcare sector. This can include sharing new research findings or offering expert commentary based on credible information.
As Jill does not have a specific geographic focus mentioned, pitches should cater to a broad audience without regional limitations.
This information evolves through artificial intelligence and human feedback. Improve this profile .